Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.


Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
06 2020
Historique:
entrez: 6 6 2020
pubmed: 6 6 2020
medline: 3 8 2021
Statut: ppublish

Résumé

The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN panel meets at least annually to review comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. Current management of classic HL involves initial treatment with chemotherapy alone or combined modality therapy followed by restaging with PET/CT to assess treatment response. Overall, the introduction of less toxic and more effective regimens has significantly advanced HL cure rates. This portion of the NCCN Guidelines focuses on the management of classic HL.

Identifiants

pubmed: 32502987
doi: 10.6004/jnccn.2020.0026
pii: jnccnGLS1806
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

755-781

Auteurs

Richard T Hoppe (RT)

1Stanford Cancer Institute.

Ranjana H Advani (RH)

1Stanford Cancer Institute.

Weiyun Z Ai (WZ)

2UCSF Helen Diller Family Comprehensive Cancer Center.

Richard F Ambinder (RF)

3The Sidney Kimmel Comprehensive Cancer Center at John Hopkins.

Philippe Armand (P)

4Dana-Farber/Brigham and Women's Cancer Center.

Celeste M Bello (CM)

5Moffitt Cancer Center.

Cecil M Benitez (CM)

1Stanford Cancer Institute.

Philip J Bierman (PJ)

6Fred & Pamela Buffett Cancer Center.

Kirsten M Boughan (KM)

7Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Bouthaina Dabaja (B)

8The University of Texas MD Anderson Cancer Center.

Leo I Gordon (LI)

9Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Francisco J Hernandez-Ilizaliturri (FJ)

10Roswell Park Comprehensive Cancer Center.

Alex F Herrera (AF)

11City of Hope National Medical Center.

Ephraim P Hochberg (EP)

12Massachusetts General Hospital Cancer Center.

Jiayi Huang (J)

13Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Patrick B Johnston (PB)

14Mayo Clinic Cancer Center.

Mark S Kaminski (MS)

15University of Michigan Rogel Cancer Center.

Vaishalee P Kenkre (VP)

16University of Wisconsin Carbone Cancer Center.

Nadia Khan (N)

17Fox Chase Cancer Center.

Ryan C Lynch (RC)

18Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Kami Maddocks (K)

19The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Jonathan McConathy (J)

20O'Neal Comprehensive Cancer Center at UAB.

Matthew McKinney (M)

21Duke Cancer Institute.

Monika Metzger (M)

22St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.

David Morgan (D)

23Vanderbilt-Ingram Cancer Center.

Carolyn Mulroney (C)

24UC San Diego Moores Cancer Center.

Rachel Rabinovitch (R)

25University of Colorado Cancer Center.

Karen C Rosenspire (KC)

26Abramson Cancer Center at the University of Pennsylvania.

Stuart Seropian (S)

27Yale Cancer Center/Smilow Cancer Hospital.

Randa Tao (R)

28Huntsman Cancer Institute at the University of Utah.

Jane N Winter (JN)

9Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Joachim Yahalom (J)

29Memorial Sloan Kettering Cancer Center; and.

Jennifer L Burns (JL)

30National Comprehensive Cancer Network.

Ndiya Ogba (N)

30National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH